Skip to main content
. 2017 Nov 23;11:653. doi: 10.3389/fnins.2017.00653

Table 1.

The main characteristics of the asthma cohort (n = 167).

Parameters
Age (years) 48 (36–58)
Gender (f/m) 91/76
Smoker (n/y) 145/22
Smoking (years) 0 (0–1)
Smoking (pack-years) 0 (0–3.375)
Diabetes (n/y) 159/8
Dyslipidemia (n/y) 118/49
RR systolic (mmHg) 131.56 ± 15.24
RR diastolic (mmHg) 84.31 ± 10.68
Hypertension (n/y) 104/63
Disease duration (years) 15 (10–20)
Waist (cm) 96.37 ± 13.07
Weight (kg) 75 (65–88)
Height (m) 1.68 ± 0.10
Irisin (ng/mL) 7.87 (7.15–8.82)
BDNF (ng/mL) 314.46 ± 118.68
Urea (mmol/L) 4.4 (3.9–5.5)
Creatinine (μmol/L) 69 (58–79)
GFR (ml/min/1.73 m2) 91 (85–91)
GOT (U/L) 19.5 (16–25)
GPT (U/L) 19 (14–29)
γGT (U/L) 22 (16–33)
CK (U/L) 111.5 (81–160)
LDH (U/L) 196 (180–224)
Glucose (mmol/L) 5 (4.3–5.4)
Insulin (mU/L) 9.1 (6.3–17)
HgA1C (%) 5.4 (5–5.8)
HOMA 2.00 (1.30–4.13)
Cholesterol (mmol/L) 5.30 ± 1.18
LDL-C (mmol/L) 3.16 ± 0.93
HDL-C (mmol/L) 1.4 (1.2–1.8)
Apo-A1 (g/L) 1.59 ± 0.29
ApoB (g/L) 0.99 (0.85–1.18)
Lp(a) (mg/L) 122.5 (52–376)
TG (mmol/L) 1.3 (0.9–2)
CRP (high/low) 30/136
Fibrinogen (g/L) 3.33 ± 0.64
Procalcitonin (μg/L) 0 (0–0)
Steroid use (n/y) 11/156
SGRQ symptoms score 28.65 (11.70–51.75)
SGRQ impacts score 22.53 (8.93–38.44)
SGRQ activity score 47.24 (23.61–59.45)
SGRQ total score 32.16 (17.10–47.11)

Data are presented as mean ± SD or median (interquartile range) unless otherwise stated. f/m, female/male; y/n, yes/no; SGRQ, St. George's Respiratory Questionnaire.